mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.0029 |
0.9 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.023 |
0.9 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.0021 |
0.9 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
0.0023 |
1 |